Skip to content

Earnings yield at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
3.6%-1.9pp
Merck & Co. logo
Merck & Co.MRK
3%-4.7pp
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-10.8%-2.6pp
UroGen Pharma logo
UroGen PharmaURGN
-15.2%-4.6pp
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
-4.8%-2.1pp
CG Oncology logo
CG OncologyCGON
-3.3%-1.0pp

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Calculated from Aura Biosciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s earnings yield?
Aura Biosciences, Inc. (AURA) reported earnings yield of -26.2% in Q1 2026.
How has Aura Biosciences, Inc.'s earnings yield changed year-over-year?
Aura Biosciences, Inc.'s earnings yield increased by 18.6% year-over-year, from -32.2% to -26.2%.
What is the long-term trend for Aura Biosciences, Inc.'s earnings yield?
Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s earnings yield has grown at a 44.1% compound annual growth rate (CAGR), from -7.1% to -30.7%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.